Article

Cancer Treatment Advances Highlight Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/cancer-treatment-advances-highlight-specialty-phar" target="_blank">View the story "Cancer Treatment Advances Highlight Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Related Content
Las Vegas strip, Aerial view
April 25th 2025

Asembia's AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers

Luke Halpern, Assistant Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Gout tophus, photomicrograph showing amorphous, eosinophilic material with a foreign-body giant cell reaction and inflammation
April 25th 2025

JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition

Luke Halpern, Assistant Editor
Pharmacy focus podcast
March 28th 2025

From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

Alexandra Gerlach, Associate Editor
Nasopharyngeal carcinoma -- Image credit: Matthieu | stock.adobe.com
April 24th 2025

FDA Approves Penpulimab-Kcqx for Indications in Nonkeratinizing Nasopharyngeal Carcinoma

Gillian McGovern, Associate Editor
Antibody (Ab), also known as an immunoglobulin (Ig). 3d vector.
April 24th 2025

Intravenous Immunoglobulin Does Not Improve Clinical Outcomes Compared With Tocilizumab in Severe COVID-19

Luke Halpern, Assistant Editor